The seroprevalence of HAV IgG among Korean plasmapheresis donors is lowest in those aged 30-40s, suggesting this group should be prioritized for HAV vaccination to prevent transfusion-transmitted infections during outbreaks.
Answers are grounded in this paper and cite their sources.
May inform donor vaccination priorities; leaves open transfusion risk implications without prospective data.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Kang et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: